Prosecution Insights
Last updated: April 19, 2026

Examiner: ORTIZ, ADAM C

Tech Center 3600 • Art Units: 3673

This examiner grants 66% of resolved cases

Performance Statistics

65.7%
Allow Rate
+13.7% vs TC avg
380
Total Applications
+35.6%
Interview Lift
881
Avg Prosecution Days
Based on 353 resolved cases, 2023–2026

Rejection Statute Breakdown

0.1%
§101 Eligibility
23.0%
§102 Novelty
49.0%
§103 Obviousness
20.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18395261 CHILD CRIB Final Rejection WONDERLAND SWITZERLAND AG
18949504 ARTICULATING BOLSTER AND METHODS OF USE Non-Final OA Sizewise Rentals L.L.C.
18959020 SURGICAL TABLE Non-Final OA Warsaw Orthopedic, Inc.
18944171 INTEGRATED BED SHEET SYSTEM & DUVET SYSTEM & FOLDING BOARD Non-Final OA TRUUCE INC.
18812973 Patient Transfer Device Non-Final OA Njord International AB
17875511 Pressure Injury Relief System Final Rejection INNOVITAL LLC
18794626 Patient Turning Apparatus and Method Non-Final OA FRONTIER THERAPEUTICS LIMITED
18771615 BEDDING COVER AND INSERT Non-Final OA DAISY CUTTER, LLC
18652495 CABINET BED Final Rejection Mark Valone
18369753 FOLDABLE CHAIR AND REINFORCEMENT STRUCTURE FOR LEG PIPE Final Rejection New-Tec Integration (Xiamen) Co., Ltd.
18688487 INFLATABLE SUPPORT Non-Final OA GBUK Group Limited
18544911 PATIENT SLING Non-Final OA Human Care HC AB
18365565 Wall Bed System and Method of Assembly Final Rejection Embed Home Products Inc.
18076982 MULTI-STAGE CONVERTIBLE CRIB Non-Final OA Bexco Enterprises, Inc.
17975533 INFLATABLE DEVICE WITH ERROR-PREVENTION ASPECTS Final Rejection OPAD Airway Inc.
17909528 Bed Comprising a Foldable Board and a Foldable Mattress Final Rejection M/S LIFELINE PHARMA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month